Validation of the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) for the Australian and New Zealand population

Respirology

Volumn 16, Issue 8, 2011, Pages 1235-1240

  Ganderton, Louise ^a,b,c   Jenkins, Sue ^a,c,d   McKenna, Stephen P ^g   Gain, Kevin ^a,b,e   Fowler, Robin ^a,b,c   Twiss, James ^g   Gabbay, Eli ^a,b,c,e,f  

^a CURTIN UNIVERSITY   (Australia)

^b ROYAL PERTH HOSPITAL   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^e UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^f UNIVERSITY OF NOTRE DAME   (Australia)

^g GALEN RESEARCH   (United Kingdom)

Author keywords

health status indicator; patient reported outcome; pulmonary hypertension; quality of life; validation study

Indexed keywords

ADULT; AGED; ARTICLE; AUSTRALIA; CAMBRIDGE PULMONARY HYPERTENSION OUTCOME REVIEW; CLINICAL ARTICLE; CLINICAL ASSESSMENT TOOL; COHORT ANALYSIS; CONSTRUCT VALIDITY; FEMALE; HUMAN; INTERNAL CONSISTENCY; MALE; NEW ZEALAND; NOMENCLATURE; PATIENT CODING; PHYSICAL DISABILITY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; QUALITY OF LIFE; SEMI STRUCTURED INTERVIEW; SYMPTOMATOLOGY; TEST RETEST RELIABILITY; WRITTEN LANGUAGE;

AGED; AUSTRALIA; COHORT STUDIES; DYSPNEA; EXERCISE TOLERANCE; FEMALE; HUMANS; HYPERTENSION, PULMONARY; MALE; NEW ZEALAND; OUTCOME ASSESSMENT (HEALTH CARE); QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS;

EID: 80155202715     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2011.02030.x     Document Type: Article

References (29)

1. Mereles D, Ehlken N, Kreuscher S, et al,. Exercise and respiratory training improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension. Circulation 2006; 114: 1482-9. (Pubitemid 44527003)
2. Bauer R, Dehnert C, Schoene P, et al,. Skeletal muscle dysfunction in patients with idiopathic pulmonary arterial hypertension. Respir. Med. 2007; 101: 2366-9. (Pubitemid 47471400)
3. Badesch D, Abman S, Ahearn G, et al,. Medical therapy for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 2004; 126: 35S-62S. (Pubitemid 38932341)
4. Galiè N, Torbicki A, Barst R, et al,. Guidelines on diagnosis and treatment of pulmonary arterial hypertension. Eur. Heart J. 2004; 25: 2243-78.
5. Shafazand S, Goldstein M, Doyle R, et al,. Health-related quality of life in patients with pulmonary arterial hypertension. Chest 2004; 126: 1452-60.
6. Sitbon O, Humbert M, Nunes H, et al,. Long-term intravenous epoprostenol infusion in primary pulmonary hypertension. J. Am. Coll. Cardiol. 2002; 40: 780-8. (Pubitemid 34925627)
7. Desai S, Channick R,. Exercise in patients with pulmonary arterial hypertension. J. Cardiopulm. Rehabil. Prev. 2008; 28: 12-16. (Pubitemid 351271739)
8. Cenedese E, Speich R, Dorschner L, et al,. Measurement of quality of life in pulmonary hypertension and its significance. Eur. Respir. J. 2006; 28: 808-15. (Pubitemid 46332003)
9. Chua R, Keogh A, Byth K, et al,. Comparison and validation of three measures of quality of life in patients with pulmonary hypertension. Intern. Med. J. 2006; 36: 705-10. (Pubitemid 44563431)
10. Souza R, Martins C, Jardim C, et al,. Effect of sitaxsentan treatment on quality of life in pulmonary arterial hypertension. Int. J. Clin. Pract. 2007; 61: 153-6.
11. Taichman D, Shin J, Hud L, et al,. Health-related quality of life in patients with pulmonary arterial hypertension. Respir. Res. 2005; 6: 92.
12. White J, Hopkins R, Glissmeyer E, et al,. Cognitive, emotional, and quality of life outcomes in patients with pulmonary arterial hypertension. Respir. Res. 2006; 7: 55.
13. Zlupko M, Harhay M, Gallop R, et al,. Evaluation of disease-specific health-related quality of life in patients with pulmonary arterial hypertension. Respir. Med. 2008; 102: 1431-8.
14. Wilson I, Cleary P,. Linking clinical variables with health-related quality of life: a conceptual model of patient outcomes. JAMA 1995; 273: 59-65.
15. Peacock A, Naeije R, Galiè N, et al,. End-points and clinical trial design in pulmonary arterial hypertension: have we made progress? Eur. Respir. J. 2009; 34: 231-42.
16. Chen H, Taichman D, Doyle R,. Health-related quality of life and patient-reported outcomes in pulmonary arterial hypertension. Proc. Am. Thorac. Soc. 2008; 5: 623-30. (Pubitemid 352031535)
17. Hoeper M, Oudiz R, Peakock A, et al,. End points and clinical trial designs in pulmonary arterial hypertension. J. Am. Coll. Cardiol. 2004; 43: 48S-55S.
18. Hawthorne G, Osborne R, Taylor A, et al,. The SF36 Version 2: critical analyses of population weights, scoring algorithms and population norms. Qual. Life Res. 2007; 16: 661-73. (Pubitemid 46474952)
19. McCallum J,. The SF-36 in an Australian sample: validating a new, generic health status measure. Aust. J. Public Health 1995; 19: 160-6.
20. Doward L, Meads D, Thorsen H,. Requirements for quality of life instruments in clinical research. Value Health 2004; 7 (Suppl. 1): S13-16. (Pubitemid 39390824)
21. Guyatt G, Feeny D, Patrick D,. Measuring health-related quality of life. Ann. Intern. Med. 1993; 118: 622-9. (Pubitemid 23102698)
22. McKenna S, Doughty N, Meads D, et al,. The Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR): a measure of health-related quality of life and quality of life for patients with pulmonary hypertension. Qual. Life Res. 2006; 15: 103-15. (Pubitemid 43097591)
23. Gomberg-Maitland M, Thenappan T, Rizvi K, et al,. United States validation of the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR). J. Heart Lung Transplant. 2007; 27: 124-30.
24. Coffin D, Duval K, Martel S, et al,. Adaptation of the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) into French-Canadian and English-Canadian. Can. Respir. J. 2008; 15: 77-83. (Pubitemid 351676395)
25. Simonneau G, Galiè N, Rubin L, et al,. Clinical classification of pulmonary hypertension. J. Am. Coll. Cardiol. 2004; 43: 5S-12S. (Pubitemid 38759712)
26. Portney L, Watkins M,. Correlation. In:, Cohen M, (ed.) Foundations of Clinical Research: Applications to Practice, 3rd edn. Pearson Education, Upper Saddle River, NJ, 2009; 523-38.
27. Streiner D, Norman G,. Health Measurement Scales: A Practical Guide to Their Development and Us, 2nd edn. Oxford University Press, New York, 1995.
28. Hyland M,. A brief guide to the selection of quality of life instrument. Health Qual. Life Outcomes 2003; 1: 24.
29. Benza R, Miller D, Gomberg-Maitland M, et al,. Predicting survival in pulmonary arterial hypertension: insights from the registry to evaluate early and long-term pulmonary arterial hypertension disease management (REVEAL). Circulation 2010; 122: 164-72.